EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[Diffuse Large B-cell Lymphoma ³»½Ã°æ ¼Ò°ß] - ðû

2022-9-28 À±»óÀº ±³¼ö´Ô °­ÀÇ

1. Mass with ulceration: similar to AGC B-II

2. Ulceroinfiltrative lesion: similar to AGC B-III

3. Very Bizarre mixed elevated and depressed lesion(s)

4. EGC-like lesions

5. Multiple lesion with various morphology

6. Diffuse type: similar to AGC B-IV

7. Others

8. References


1. Mass with deep ulceration: similar to AGC B-II

Å« massÀÌ°í Áß¾Ó¿¡ ³ÐÀº ±Ë¾çÀÌ ÀÖ½À´Ï´Ù. ±Ë¾ç ¿·ÀÇ À¶±âºÎ´Â BGU¿¡¼­ º¸ÀÌ´Â edematous marginÀÌ ¾Æ´Ï¶ó ±Ë¾çÀ» µÑ·¯½Î°í ÀÖ´Â °ß°íÇÑ heaped up marginÀÔ´Ï´Ù. AGC B-II Ä¡°í´Â ³Ê¹« Å©°í, AGC-B-III Ä¡°í´Â ³Ê¹« ±ú²ýÇÕ´Ï´Ù. AGC°¡ À̸¸Å­ Å« °æ¿ì´Â º¸Åë Á» ´õ infiltrativeÇÑ ¾ç»óÀ» º¸ÀÌ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±×·¡¼­ lymphoma¸¦ ÀǽÉÇØ¾ß ÇÕ´Ï´Ù. (¸ñ¿äÁ¡½ÉÁý´ãȸ 20160602)

ÀӽŠµµÁß ¹ß°ßµÈ À§ ¸²ÇÁÁ¾ (2013). Borrmann type II¿Í À¯»çÇÑ ºÎÀ§°¡ ÀÖÁö¸¸ ÁÖº¯À¸·Îµµ infiltrationÇÑ ¾ç»ó°ú ÀÛÀº ±Ë¾çµµ ÀÖÀ½.
CD 10 (CALLA) : Negative
Bcl-6 : Positive in tumor cells (90 %)
MUM-1(IRF-4) : Positive in tumor cells (30 %)
CD 20 L26 : Positive in tumor cells
Ki-67 : Positive in 99 % of tumor cells

Initial endoscopy
R-CHOP Ç×¾ÏÄ¡·á ÈÄ È£Àü ¼Ò°ß

EndoTODAY Quiz

[Çؼ³]

º¸¸¸ 2Çü ÁøÇ༺ À§¾Ï°ú À§¸²ÇÁÁ¾ÀÇ ±¸ºÐ¿¡ ´ëÇÑ Ç¥¸¦ ¼Ò°³ÇÕ´Ï´Ù (»óºÎ¼ÒÈ­°ü ³»½Ã°æ ¼Ò°ßÀÇ Æǵ¶ ¹× °¨º°Áø´Ü. ¹ÚÀμ­ ¿Å±è. ±ºÀÚÃâÆÇ»ç 193ÂÊ). Á¦°¡ ºÓÀº box·Î Ç¥½ÃÇÑ ºÎºÐÀ» Àß º¸½Ã±â ¹Ù¶ø´Ï´Ù. º¸¸¸ 2Çü ÁøÇ༺ À§¾ÏÀº ±Ë¾çºÎ¿Í À¶±âºÎ°¡ ¸ðµÎ ¾Ïµ¢¾î¸®ÀÔ´Ï´Ù. ¹Ý¸é ¸²ÇÁÁ¾Àº Á¡¸·ÇÏÁ¾¾çó·³ ÀÚ¶ó³­ °ÍÀ̹ǷΠ±Ë¾çºÎ´Â ¾ÏÀε¥ À¶±âºÎ´Â Á¤»ó »óÇÇ·Î µ¤ÀÎ °æ¿ì°¡ ¸¹½À´Ï´Ù.


2. Ulceroinfiltrative lesion: similar to AGC B-III


M/60 (2020)


3. Very Bizarre mixed elevated and depressed lesion(s)


4. EGC-like lesions

Initial endoscopy

CR after chemotherapy (R-CHOP 3 cycles)

Single raised erosion ºñ½ÁÇÑ DLBCLµµ ÀÖ½À´Ï´Ù.

F/60 (2020)

DLBCL of the remnant stomach (2020, ³²ÀÚ 60¼¼)

CD20


5. Multiple lesion with various morphology

2020³â ¿©ÀÚ 70¼¼. Diffuse large B cell lymphoma, not otherwise specified, germinal center B-cell type, double espressor phenotype (¾Æ·¡ º´¸® »çÁø ÂüÁ¶)


EBV-positive DLBCL

DLBCL, activated B cell type


EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
. EBV ISH : Positive (numerous, > 90%)
. Bcl-2 : Negative in tumor cells (5%)
. MUM-1(IRF-4) : Negative in tumor cells (10%)
. CD 10, (CALLA) : Positive in tumor cells (100%)
. c-myc : Positive in tumor cells (90%)
. Bcl-6 : Positive in tumor cells (90%)
. CD 3, T-CELL : Negative in tumor cells
. Ki-67 : Positive in 98% of tumor cells
. CD 20, L26 : Positive in tumor cells


6. Diffuse type: similar to AGC B-IV

º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï°ú À¯»çÇÑ Diffuse large B cell lymphomaÀÇ ³»½Ã°æÀû Ư¡
(1) ÁÖ¸§ÀÇ ºñÈÄ°¡ less homogeneousÇÏ°í (µÎ²²ÀÇ Â÷ÀÌ°¡ ÀÖ´Ù´Â ÀǹÌ)
(2) ÁÖ¸§Àº ºñÈĵǾî ÀÖÀ¸³ª °ñÂ¥±â´Â À¯ÁöµÇ´Â ÆíÀ̸ç
(3) Ç¥¸éÀÌ paleÇϸ鼭 ¸Å²öÇÏ°í ÅÊÅÊÇÑ ´À³¦À̸ç moasic patternÀ» º¸ÀÌÁö ¾ÊÀ¸¸ç
(4) ulcer³ª erosionÀÌ µå¹°°í
(5) °ø±â¸¦ ÁÖÀÔÇϸé Àß ÆìÁö´Â ÆíÀÌ´Ù.

DLBCL

DLBCL

DLBCL, activated B cell type

À§´Â diffuse large B cell lymphomaÀÇ infiltrative typeÀÎ °ÍÀ¸·Î ÀÌÇØÇÏ¸é ¹«³­ÇÒ °Í °°½À´Ï´Ù. ½ÊÀÌÁöÀå ±¸ºÎÀÇ ºÓÀº ºÎÀ§±îÁö DLBCL·Î ³ª¿Ô½À´Ï´Ù.

Localized form

¾Æ·¡´Â 2013³â 7¿ù 7ÀÏ ºÎ¿ï°æ ³»½Ã°æ ¼¼¹Ì³ª¿¡¼­ ºÎ»ê´ë ±è±¤ÇÏ ±³¼ö´Ô²²¼­ ¼Ò°³ÇÑ Áõ·ÊÀÔ´Ï´Ù. Thicked foldÀÇ °¨º°Áø´Ü¿¡ ´ëÇÏ¿© ¸ÚÁø ½½¶óÀ̵嵵 º¸¿©Áּ̽À´Ï´Ù.

Diffuse large B cell lymphoma with EBV infection (º´¸®)


7. Others

³²ÀÚ 60¼¼. ÀÜÀ§ DLBCL

F/35. Melena·Î °Ë»ç¸¦ ¹Þ¾Ò°í high grade MALToma¶ó´Â Á¶Á÷¼Ò°ßÀ¸·Î ÀǷڵǾúÀ¸³ª ³»½Ã°æ Àç°Ë¿¡¼­ diffuse large B cell lymphoma·Î È®ÀεǾî R-CHOP ½ÃÇà

SMT ÇüÅÂÀÇ gastric lymphoma
º´¸® Áø´Ü. LARGE B-CELL LYMPHOMA
Differential diagnosis; 1) diffuse large B-cell lymphoma, not otherwise specified, activated B-cell type, 2) T-cell/histiocyte rich large B-cell lymphoma (2018 SMC ¼ÒÈ­±âº´½ÉÆ÷Áö¾ö ¹Î¾ç¿ø ±³¼ö´Ô °­ÀÇ)

ù Á¶Á÷°Ë»ç¿¡¼­ undifferentiated malignant tumor, prefer sarcomatoid carcinoma·Î ³ª¿Í ¼ö¼úÀ» ÇÏ¿´°í DLBCL·Î È®ÀεǾúÀ½ (2015, M/55). DLBCL º´¼Ò°¡ µÎ °÷ÀÌ°í ¸²ÇÁÀý ÀüÀÌ°¡ ÀÖ¾úÀ½

À§¾Ï 619

8³âÀü hilar mass (diffuse large B cell lymphoma)·Î Ç×¾ÏÄ¡·á ¹Þ°í CRÀÌ´ø ȯÀÚÀÇ gastric recurrence. À§ ¸²ÇÁÁ¾Àº °£È¤ Borrmann type II¿Í ±¸ºÐÀÌ ¾î·Æ½À´Ï´Ù. ÀÌ È¯ÀÚ´Â gastric biopsy¿¡¼­µµ diffuse large B cell lymphoma°¡ ³ª¿Ô½À´Ï´Ù.

Neck DLBCL·Î Ç×¾ÏÄ¡·á ¹Þ°í CRÀÌ´ø ȯÀÚÀÇ gastric recurrence (2015)
À§ Á¶Á÷°Ë»ç: Involvement of diffuse large B cell lymphoma, recurrent
CD 3, T-CELL : Negative in tumor cells
CD 20, L26 : Negative in tumor cells
Ki-67 : Positive in 90% of tumor cells
CD 79a : Positive in tumor cells

[Çؼ³]

º¸¸¸ 2Çü ÁøÇ༺ À§¾Ï°ú À§¸²ÇÁÁ¾ÀÇ ±¸ºÐ¿¡ ´ëÇÑ Ç¥¸¦ ¼Ò°³ÇÕ´Ï´Ù (»óºÎ¼ÒÈ­°ü ³»½Ã°æ ¼Ò°ßÀÇ Æǵ¶ ¹× °¨º°Áø´Ü. ¹ÚÀμ­ ¿Å±è. ±ºÀÚÃâÆÇ»ç 193ÂÊ). Á¦°¡ ºÓÀº box·Î Ç¥½ÃÇÑ ºÎºÐÀ» Àß º¸½Ã±â ¹Ù¶ø´Ï´Ù. º¸¸¸ 2Çü ÁøÇ༺ À§¾ÏÀº ±Ë¾çºÎ¿Í À¶±âºÎ°¡ ¸ðµÎ ¾Ïµ¢¾î¸®ÀÔ´Ï´Ù. ¹Ý¸é ¸²ÇÁÁ¾Àº Á¡¸·ÇÏÁ¾¾çó·³ ÀÚ¶ó³­ °ÍÀ̹ǷΠ±Ë¾çºÎ´Â ¾ÏÀε¥ À¶±âºÎ´Â Á¤»ó »óÇÇ·Î µ¤ÀÎ °æ¿ì°¡ ¸¹½À´Ï´Ù.


MALToma-like DLBCL


[References]

1. EndoTODAY DLBCL



© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng